• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质瘤形成、癌症干细胞与Akt信号传导

Glioma formation, cancer stem cells, and akt signaling.

作者信息

Hambardzumyan Dolores, Squatrito Massimo, Carbajal Eletha, Holland Eric C

机构信息

Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

出版信息

Stem Cell Rev. 2008 Sep;4(3):203-10. doi: 10.1007/s12015-008-9021-5.

DOI:10.1007/s12015-008-9021-5
PMID:18595010
Abstract

Several recent reports have provided evidence that cancer is initiated by a rare fraction of cells called "cancer stem cells" which are multipotent, self-renewing subset of the tumor. However, several issues regarding the biology and techniques of isolating these cells from solid tumors remain to be clarified. In addition, experimental data supports two possibilities for glioma cell of origin. First, that stem cells or early progenitors are transformed and show variable differentiation of their progeny during tumor development. Second, that more differentiated glia are transformed by genetic events that lead to a loss of differentiation maintenance. In human gliomas, these two theories are not mutually exclusive. In this review we will summarize both theories, and highlight outstanding issues that remain to be resolved.

摘要

最近的几份报告提供了证据,表明癌症是由一小部分称为“癌症干细胞”的细胞引发的,这些细胞是肿瘤中具有多能性、自我更新能力的亚群。然而,关于从实体瘤中分离这些细胞的生物学和技术的几个问题仍有待阐明。此外,实验数据支持胶质瘤细胞起源的两种可能性。第一,干细胞或早期祖细胞发生转化,并在肿瘤发展过程中其后代表现出可变的分化。第二,分化程度更高的神经胶质细胞因导致分化维持丧失的基因事件而发生转化。在人类胶质瘤中,这两种理论并非相互排斥。在这篇综述中,我们将总结这两种理论,并突出仍有待解决的突出问题。

相似文献

1
Glioma formation, cancer stem cells, and akt signaling.胶质瘤形成、癌症干细胞与Akt信号传导
Stem Cell Rev. 2008 Sep;4(3):203-10. doi: 10.1007/s12015-008-9021-5.
2
Biology of glioma cancer stem cells.神经胶质瘤肿瘤干细胞的生物学特性。
Mol Cells. 2009 Jul 31;28(1):7-12. doi: 10.1007/s10059-009-0111-2. Epub 2009 Jul 20.
3
A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.一种新的 2-吡喃酮衍生物,5-溴-3-(3-羟基丙炔基)-2H-吡喃-2-酮,可抑制神经胶质瘤干细胞的干性。
Mol Pharmacol. 2012 Sep;82(3):400-7. doi: 10.1124/mol.112.078402. Epub 2012 May 30.
4
[An update: stem cell and cancer stem cells].[最新消息:干细胞与癌症干细胞]
Zhonghua Bing Li Xue Za Zhi. 2009 Aug;38(8):511-2.
5
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.缺氧通过激活缺氧诱导因子-1α(HIF-1α)促进CD133阳性胶质瘤干细胞的扩增。
Oncogene. 2009 Nov 12;28(45):3949-59. doi: 10.1038/onc.2009.252. Epub 2009 Aug 31.
6
Limits of CD133 as a marker of glioma self-renewing cells.CD133作为胶质瘤自我更新细胞标志物的局限性。
Int J Cancer. 2009 Jul 1;125(1):244-8. doi: 10.1002/ijc.24352.
7
Stem cell markers in gliomas.胶质瘤中的干细胞标志物。
Neurochem Res. 2008 Dec;33(12):2407-15. doi: 10.1007/s11064-008-9723-8. Epub 2008 May 21.
8
CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.CD133+和巢蛋白+肿瘤起始细胞在N29和N32实验性胶质瘤中占主导地位。
Int J Cancer. 2009 Jul 1;125(1):15-22. doi: 10.1002/ijc.24306.
9
[Preliminary studies on cell derivation of neovascularization in human glioma and its functional evaluation].[人胶质瘤新生血管形成的细胞来源及其功能评价的初步研究]
Zhonghua Zhong Liu Za Zhi. 2011 Oct;33(10):726-31.
10
Presence of pluripotent CD133+ cells correlates with malignancy of gliomas.存在多能性 CD133+ 细胞与神经胶质瘤的恶性程度相关。
Mol Cell Neurosci. 2010 Jan;43(1):51-9. doi: 10.1016/j.mcn.2008.07.022. Epub 2008 Aug 7.

引用本文的文献

1
Preclinical approach of two novel tetrahydroquinoline derivatives targeting GPER and Bcl-2 for anti-glioblastoma therapy.两种靶向GPER和Bcl-2的新型四氢喹啉衍生物用于抗胶质母细胞瘤治疗的临床前研究方法
Sci Rep. 2025 May 21;15(1):17710. doi: 10.1038/s41598-025-02186-6.
2
Identification of PDLIM1 as a glioblastoma stem cell marker driving tumorigenesis and chemoresistance.鉴定PDLIM1作为驱动肿瘤发生和化疗耐药的胶质母细胞瘤干细胞标志物。
Cell Death Discov. 2024 Nov 15;10(1):469. doi: 10.1038/s41420-024-02241-7.
3
Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease.

本文引用的文献

1
The PI-3kinase pathway in hematopoietic stem cells and leukemia-initiating cells: a mechanistic difference between normal and cancer stem cells.造血干细胞和白血病起始细胞中的PI-3激酶信号通路:正常干细胞与癌症干细胞之间的机制差异
Blood Cells Mol Dis. 2008 Jul-Aug;41(1):73-6. doi: 10.1016/j.bcmd.2008.02.004. Epub 2008 Apr 2.
2
Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.成人人类胶质瘤中A2B5+CD133-肿瘤起始细胞的鉴定
Neurosurgery. 2008 Feb;62(2):505-14; discussion 514-5. doi: 10.1227/01.neu.0000316019.28421.95.
3
Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas.
Prominin-1(CD133)在健康和疾病中参与质膜结构和细胞信号通路动态变化的新兴作用。
Cell Mol Biol Lett. 2024 Mar 26;29(1):41. doi: 10.1186/s11658-024-00554-0.
4
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma.序贯靶向策略打断胶质母细胞瘤中 AKT 驱动的亚克隆介导的进展。
Clin Cancer Res. 2023 Jan 17;29(2):488-500. doi: 10.1158/1078-0432.CCR-22-0611.
5
In Silico Analysis of the Correlation of KIF2C with Prognosis and Immune Infiltration in Glioma.基于计算机的分析显示 KIF2C 与脑胶质瘤患者预后和免疫浸润的相关性。
Comput Math Methods Med. 2022 Mar 27;2022:6320828. doi: 10.1155/2022/6320828. eCollection 2022.
6
Necrotic reshaping of the glioma microenvironment drives disease progression.肿瘤坏死重塑胶质瘤微环境促进疾病进展。
Acta Neuropathol. 2022 Mar;143(3):291-310. doi: 10.1007/s00401-021-02401-4. Epub 2022 Jan 17.
7
Knockdown of ETV4 promotes autophagy-dependent apoptosis in GBM cells by reducing the transcriptional activation of EMP1.敲低ETV4可通过降低EMP1的转录激活来促进胶质母细胞瘤细胞中自噬依赖性凋亡。
Oncol Lett. 2022 Feb;23(2):41. doi: 10.3892/ol.2021.13159. Epub 2021 Dec 6.
8
Implication of Lactucopicrin in Autophagy, Cell Cycle Arrest and Oxidative Stress to Inhibit U87Mg Glioblastoma Cell Growth.乳蓟苦素通过自噬、细胞周期阻滞和氧化应激抑制 U87MG 神经胶质瘤细胞生长的作用机制。
Molecules. 2020 Dec 10;25(24):5843. doi: 10.3390/molecules25245843.
9
Combined PI3Kα-mTOR Targeting of Glioma Stem Cells.针对胶质瘤干细胞的 PI3Kα-mTOR 联合靶向治疗。
Sci Rep. 2020 Dec 14;10(1):21873. doi: 10.1038/s41598-020-78788-z.
10
A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cells.CD133-AKT-Wnt 信号轴驱动脑胶质瘤肿瘤起始细胞。
Oncogene. 2020 Feb;39(7):1590-1599. doi: 10.1038/s41388-019-1086-x. Epub 2019 Nov 6.
在血小板衍生生长因子诱导的胶质瘤中,Gli活性与肿瘤分级相关。
Cancer Res. 2008 Apr 1;68(7):2241-9. doi: 10.1158/0008-5472.CAN-07-6350.
4
CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors.CD133表达及癌症干细胞可预测高级别少突胶质细胞瘤的预后。
Brain Pathol. 2008 Jul;18(3):370-7. doi: 10.1111/j.1750-3639.2008.00130.x. Epub 2008 Mar 26.
5
PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo.PI3K信号通路调节髓母细胞瘤体内放疗后血管周围微环境中癌干细胞的存活。
Genes Dev. 2008 Feb 15;22(4):436-48. doi: 10.1101/gad.1627008.
6
Stem cell marker CD133 affects clinical outcome in glioma patients.干细胞标志物CD133影响胶质瘤患者的临床预后。
Clin Cancer Res. 2008 Jan 1;14(1):123-9. doi: 10.1158/1078-0432.CCR-07-0932.
7
Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations.靶向PI3K/Akt/mTOR通路:有效联合方案及临床考量
Drug Resist Updat. 2008 Feb-Apr;11(1-2):32-50. doi: 10.1016/j.drup.2007.11.003. Epub 2007 Dec 31.
8
Reinduction of ErbB2 in astrocytes promotes radial glial progenitor identity in adult cerebral cortex.星形胶质细胞中ErbB2的重新诱导促进成年大脑皮质中的放射状胶质祖细胞特性。
Genes Dev. 2007 Dec 15;21(24):3258-71. doi: 10.1101/gad.1580407.
9
Cellular niches for endogenous neural stem cells in the adult brain.成体大脑中内源性神经干细胞的细胞龛
CNS Neurol Disord Drug Targets. 2007 Oct;6(5):336-41. doi: 10.2174/187152707783220866.
10
CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells.CD133阴性胶质瘤细胞在裸鼠体内形成肿瘤,并产生CD133阳性细胞。
Int J Cancer. 2008 Feb 15;122(4):761-8. doi: 10.1002/ijc.23130.